University College London - Institute of Neurology & The National Hospital for Neurology and Neurosurgery Trials

University College London - Institute of Neurology & The National Hospital for Neurology and Neurosurgery	Welcome, Profile Billing Logout

University College London - Institute of Neurology & The National Hospital for Neurology and Neurosurgery

Welcome, Profile Billing Logout

0 Trials

1 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Begum, Shazia

IMC-F106C-101, NCT04262466 / 2019-004046-16: Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Oct 2024 - Dec 2024 : Data for late-line NSCLC

Recruiting

1/2

727

Europe, Canada, US, RoW

Brenetafusp, Brenetafusp and pembrolizumab, Brenetafusp and chemotherapy, Brenetafusp and monoclonal antibodies and chemotherapy, Brenetafusp and tebentafusp, Brenetafusp and bevacizumab, Brenetafusp and kinase inhibitors

Immunocore Ltd

Select Advanced Solid Tumors

02/26

08/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites